Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 6,161,000 | 6,197,000 | 5,737,000 | 5,871,000 | 5,557,000 |
| Cost of Goods | 1,513,000 | 1,253,000 | 1,036,000 | 1,012,000 | 1,055,000 |
| Gross Profit | 4,648,000 | 4,944,000 | 4,701,000 | 4,859,000 | 4,502,000 |
| Operating Expenses | 2,293,000 | 2,896,000 | 2,225,000 | 2,181,000 | 2,030,000 |
| Operating Income | 2,355,000 | 2,048,000 | 2,476,000 | 2,678,000 | 2,472,000 |
| Interest Expense | 346,000 | 301,000 | 313,000 | 332,000 | 343,000 |
| Other Income | 11,000 | 236,000 | 114,000 | 218,000 | 185,000 |
| Pre-tax Income | 2,020,000 | 1,983,000 | 2,277,000 | 2,564,000 | 2,314,000 |
| Income Tax | 195,000 | 280,000 | 309,000 | 385,000 | 322,000 |
| Net Income Continuous | 1,825,000 | 1,703,000 | 1,968,000 | 2,179,000 | 1,992,000 |
| Net Income | $1,825,000 | $1,703,000 | $1,968,000 | $2,179,000 | $1,992,000 |
| EPS Basic Total Ops | 3.09 | 2.88 | 3.29 | 3.59 | 3.20 |
| EPS Basic Continuous Ops | 3.09 | 2.88 | 3.29 | 3.59 | 3.20 |
| EPS Diluted Total Ops | 3.07 | 2.86 | 3.27 | 3.57 | 3.18 |
| EPS Diluted Continuous Ops | 3.07 | 2.85 | 3.27 | 3.57 | 3.18 |
| EBITDA(a) | $3,252,000 | $2,750,000 | $2,984,000 | $3,179,000 | $2,967,000 |